Selected research
Market Structure
Global Vendor Neutral Archive (VNA) & PACS Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Vendor Neutral Archive (VNA) & PACS market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Vendor Neutral Archive (VNA) & PACS is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Vendor Neutral Archive (VNA) & PACS is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Vendor Neutral Archive (VNA) & PACS is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Vendor Neutral Archive (VNA) & PACS is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Vendor Neutral Archive (VNA) & PACS include GE Healthcare Technologies Inc., Siemens Healthcare Limited, Canon Medical Systems Corporation, FUJIFILM Holdings Corporation, Agfa-Gevaert Group, Sectra AB, Hyland Software, Inc., Intelerad Medical Systems Inc and Merative, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Vendor Neutral Archive (VNA) & PACS market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Vendor Neutral Archive (VNA) & PACS and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Vendor Neutral Archive (VNA) & PACS revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Vendor Neutral Archive (VNA) & PACS market size, projected growth trends, production technologies, key applications, and end-use industries.
Vendor Neutral Archive (VNA) & PACS Segment by Company
GE Healthcare Technologies Inc.
Siemens Healthcare Limited
Canon Medical Systems Corporation
FUJIFILM Holdings Corporation
Agfa-Gevaert Group
Sectra AB
Hyland Software, Inc.
Intelerad Medical Systems Inc
Merative
Novarad Corporation
Esaote SPA
Dedalus s.p.A.
BridgeHead Software Ltd.
PaxeraHealth
Medicasoft
Visus Health IT GmbH
POSTDICOM
Vendor Neutral Archive (VNA) & PACS Segment by Type
CT
MRl
X-rays
Ultrasound
Mammo
PET
Vendor Neutral Archive (VNA) & PACS Segment by Application
Hospital
Surgery Center
Other
Vendor Neutral Archive (VNA) & PACS Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vendor Neutral Archive (VNA) & PACS market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Vendor Neutral Archive (VNA) & PACS and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vendor Neutral Archive (VNA) & PACS.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Vendor Neutral Archive (VNA) & PACS in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Vendor Neutral Archive (VNA) & PACS industry.
Chapter 3: Detailed analysis of Vendor Neutral Archive (VNA) & PACS companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Vendor Neutral Archive (VNA) & PACSrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- CT
- MRl
- X-rays
- Ultrasound
- Mammo
- PET
Applications
- Hospital
- Surgery Center
- Other
Companies covered
- GE Healthcare Technologies Inc.
- Siemens Healthcare Limited
- Canon Medical Systems Corporation
- FUJIFILM Holdings Corporation
- Agfa-Gevaert Group
- Sectra AB
- Hyland Software, Inc.
- Intelerad Medical Systems Inc
- Merative
- Novarad Corporation
- Esaote SPA
- Dedalus s.p.A.
- BridgeHead Software Ltd.
- PaxeraHealth
- Medicasoft
- Visus Health IT GmbH
- POSTDICOM
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Vendor Neutral Archive (VNA) & PACS Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 CT
- 1.2.3 MRl
- 1.2.4 X-rays
- 1.2.5 Ultrasound
- 1.2.6 Mammo
- 1.2.7 PET
- 1.3 Market Analysis by Application
- 1.3.1 Global Vendor Neutral Archive (VNA) & PACS Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Hospital
- 1.3.3 Surgery Center
- 1.3.4 Other
- 1.4 Global Market Growth Prospects
- 1.5 Global Vendor Neutral Archive (VNA) & PACS Growth Trends by Region
- 1.5.1 Global Vendor Neutral Archive (VNA) & PACS Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Vendor Neutral Archive (VNA) & PACS Market Size by Region (2021-2026)
- 1.5.3 Vendor Neutral Archive (VNA) & PACS Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Vendor Neutral Archive (VNA) & PACS Market Dynamics
- 2.1 Vendor Neutral Archive (VNA) & PACS Industry Trends
- 2.2 Vendor Neutral Archive (VNA) & PACS Industry Drivers
- 2.3 Vendor Neutral Archive (VNA) & PACS Industry Opportunities and Challenges
- 2.4 Vendor Neutral Archive (VNA) & PACS Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Vendor Neutral Archive (VNA) & PACS Revenue by Company (2021-2026)
- 3.2 Global Vendor Neutral Archive (VNA) & PACS Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Vendor Neutral Archive (VNA) & PACS Key Company Head office and Area Served
- 3.4 Global Vendor Neutral Archive (VNA) & PACS Company, Product Type & Application
- 3.5 Global Vendor Neutral Archive (VNA) & PACS Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Vendor Neutral Archive (VNA) & PACS Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Vendor Neutral Archive (VNA) & PACS Players Market Share by Revenue in 2025
- 3.6.3 2025 Vendor Neutral Archive (VNA) & PACS Tier 1, Tier 2, and Tier 3
4 Vendor Neutral Archive (VNA) & PACS Market by Type
- 4.1 Global Vendor Neutral Archive (VNA) & PACS Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Vendor Neutral Archive (VNA) & PACS Market Size by Type (2021-2032)
- 4.3 Global Vendor Neutral Archive (VNA) & PACS Market Size Share by Type (2021-2032)
5 Vendor Neutral Archive (VNA) & PACS Market by Application
- 5.1 Global Vendor Neutral Archive (VNA) & PACS Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Vendor Neutral Archive (VNA) & PACS Market Size by Application (2021-2032)
- 5.3 Global Vendor Neutral Archive (VNA) & PACS Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 GE Healthcare Technologies Inc.
- 6.1.1 GE Healthcare Technologies Inc. Company Information
- 6.1.2 GE Healthcare Technologies Inc. Business Overview
- 6.1.3 GE Healthcare Technologies Inc. Vendor Neutral Archive (VNA) & PACS Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 GE Healthcare Technologies Inc. Vendor Neutral Archive (VNA) & PACS Product Portfolio
- 6.1.5 GE Healthcare Technologies Inc. Recent Developments
- 6.2 Siemens Healthcare Limited
- 6.2.1 Siemens Healthcare Limited Company Information
- 6.2.2 Siemens Healthcare Limited Business Overview
- 6.2.3 Siemens Healthcare Limited Vendor Neutral Archive (VNA) & PACS Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Siemens Healthcare Limited Vendor Neutral Archive (VNA) & PACS Product Portfolio
- 6.2.5 Siemens Healthcare Limited Recent Developments
- 6.3 Canon Medical Systems Corporation
- 6.3.1 Canon Medical Systems Corporation Company Information
- 6.3.2 Canon Medical Systems Corporation Business Overview
- 6.3.3 Canon Medical Systems Corporation Vendor Neutral Archive (VNA) & PACS Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Canon Medical Systems Corporation Vendor Neutral Archive (VNA) & PACS Product Portfolio
- 6.3.5 Canon Medical Systems Corporation Recent Developments
- 6.4 FUJIFILM Holdings Corporation
- 6.4.1 FUJIFILM Holdings Corporation Company Information
- 6.4.2 FUJIFILM Holdings Corporation Business Overview
- 6.4.3 FUJIFILM Holdings Corporation Vendor Neutral Archive (VNA) & PACS Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 FUJIFILM Holdings Corporation Vendor Neutral Archive (VNA) & PACS Product Portfolio
- 6.4.5 FUJIFILM Holdings Corporation Recent Developments
- 6.5 Agfa-Gevaert Group
- 6.5.1 Agfa-Gevaert Group Company Information
- 6.5.2 Agfa-Gevaert Group Business Overview
- 6.5.3 Agfa-Gevaert Group Vendor Neutral Archive (VNA) & PACS Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Agfa-Gevaert Group Vendor Neutral Archive (VNA) & PACS Product Portfolio
- 6.5.5 Agfa-Gevaert Group Recent Developments
- 6.6 Sectra AB
- 6.6.1 Sectra AB Company Information
- 6.6.2 Sectra AB Business Overview
- 6.6.3 Sectra AB Vendor Neutral Archive (VNA) & PACS Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Sectra AB Vendor Neutral Archive (VNA) & PACS Product Portfolio
- 6.6.5 Sectra AB Recent Developments
- 6.7 Hyland Software, Inc.
- 6.7.1 Hyland Software, Inc. Company Information
- 6.7.2 Hyland Software, Inc. Business Overview
- 6.7.3 Hyland Software, Inc. Vendor Neutral Archive (VNA) & PACS Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Hyland Software, Inc. Vendor Neutral Archive (VNA) & PACS Product Portfolio
- 6.7.5 Hyland Software, Inc. Recent Developments
- 6.8 Intelerad Medical Systems Inc
- 6.8.1 Intelerad Medical Systems Inc Company Information
- 6.8.2 Intelerad Medical Systems Inc Business Overview
- 6.8.3 Intelerad Medical Systems Inc Vendor Neutral Archive (VNA) & PACS Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Intelerad Medical Systems Inc Vendor Neutral Archive (VNA) & PACS Product Portfolio
- 6.8.5 Intelerad Medical Systems Inc Recent Developments
- 6.9 Merative
- 6.9.1 Merative Company Information
- 6.9.2 Merative Business Overview
- 6.9.3 Merative Vendor Neutral Archive (VNA) & PACS Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Merative Vendor Neutral Archive (VNA) & PACS Product Portfolio
- 6.9.5 Merative Recent Developments
- 6.10 Novarad Corporation
- 6.10.1 Novarad Corporation Company Information
- 6.10.2 Novarad Corporation Business Overview
- 6.10.3 Novarad Corporation Vendor Neutral Archive (VNA) & PACS Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Novarad Corporation Vendor Neutral Archive (VNA) & PACS Product Portfolio
- 6.10.5 Novarad Corporation Recent Developments
- 6.11 Esaote SPA
- 6.11.1 Esaote SPA Company Information
- 6.11.2 Esaote SPA Business Overview
- 6.11.3 Esaote SPA Vendor Neutral Archive (VNA) & PACS Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Esaote SPA Vendor Neutral Archive (VNA) & PACS Product Portfolio
- 6.11.5 Esaote SPA Recent Developments
- 6.12 Dedalus s.p.A.
- 6.12.1 Dedalus s.p.A. Company Information
- 6.12.2 Dedalus s.p.A. Business Overview
- 6.12.3 Dedalus s.p.A. Vendor Neutral Archive (VNA) & PACS Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Dedalus s.p.A. Vendor Neutral Archive (VNA) & PACS Product Portfolio
- 6.12.5 Dedalus s.p.A. Recent Developments
- 6.13 BridgeHead Software Ltd.
- 6.13.1 BridgeHead Software Ltd. Company Information
- 6.13.2 BridgeHead Software Ltd. Business Overview
- 6.13.3 BridgeHead Software Ltd. Vendor Neutral Archive (VNA) & PACS Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 BridgeHead Software Ltd. Vendor Neutral Archive (VNA) & PACS Product Portfolio
- 6.13.5 BridgeHead Software Ltd. Recent Developments
- 6.14 PaxeraHealth
- 6.14.1 PaxeraHealth Company Information
- 6.14.2 PaxeraHealth Business Overview
- 6.14.3 PaxeraHealth Vendor Neutral Archive (VNA) & PACS Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 PaxeraHealth Vendor Neutral Archive (VNA) & PACS Product Portfolio
- 6.14.5 PaxeraHealth Recent Developments
- 6.15 Medicasoft
- 6.15.1 Medicasoft Company Information
- 6.15.2 Medicasoft Business Overview
- 6.15.3 Medicasoft Vendor Neutral Archive (VNA) & PACS Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.15.4 Medicasoft Vendor Neutral Archive (VNA) & PACS Product Portfolio
- 6.15.5 Medicasoft Recent Developments
- 6.16 Visus Health IT GmbH
- 6.16.1 Visus Health IT GmbH Company Information
- 6.16.2 Visus Health IT GmbH Business Overview
- 6.16.3 Visus Health IT GmbH Vendor Neutral Archive (VNA) & PACS Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.16.4 Visus Health IT GmbH Vendor Neutral Archive (VNA) & PACS Product Portfolio
- 6.16.5 Visus Health IT GmbH Recent Developments
- 6.17 POSTDICOM
- 6.17.1 POSTDICOM Company Information
- 6.17.2 POSTDICOM Business Overview
- 6.17.3 POSTDICOM Vendor Neutral Archive (VNA) & PACS Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.17.4 POSTDICOM Vendor Neutral Archive (VNA) & PACS Product Portfolio
- 6.17.5 POSTDICOM Recent Developments
7 North America
- 7.1 North America Vendor Neutral Archive (VNA) & PACS Market Size (2021-2032)
- 7.2 North America Vendor Neutral Archive (VNA) & PACS Market Size by Type
- 7.2.1 North America Vendor Neutral Archive (VNA) & PACS Market Size by Type (2021-2026)
- 7.2.2 North America Vendor Neutral Archive (VNA) & PACS Market Size by Type (2027-2032)
- 7.2.3 North America Vendor Neutral Archive (VNA) & PACS Market Share by Type (2021-2032)
- 7.3 North America Vendor Neutral Archive (VNA) & PACS Market Size by Application
- 7.3.1 North America Vendor Neutral Archive (VNA) & PACS Market Size by Application (2021-2026)
- 7.3.2 North America Vendor Neutral Archive (VNA) & PACS Market Size by Application (2027-2032)
- 7.3.3 North America Vendor Neutral Archive (VNA) & PACS Market Share by Application (2021-2032)
- 7.4 North America Vendor Neutral Archive (VNA) & PACS Market Size by Country
- 7.4.1 North America Vendor Neutral Archive (VNA) & PACS Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Vendor Neutral Archive (VNA) & PACS Market Size by Country (2021-2026)
- 7.4.3 North America Vendor Neutral Archive (VNA) & PACS Market Size by Country (2027-2032)
- 7.4.4 North America Vendor Neutral Archive (VNA) & PACS Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Vendor Neutral Archive (VNA) & PACS Market Size (2021-2032)
- 8.2 Europe Vendor Neutral Archive (VNA) & PACS Market Size by Type
- 8.2.1 Europe Vendor Neutral Archive (VNA) & PACS Market Size by Type (2021-2026)
- 8.2.2 Europe Vendor Neutral Archive (VNA) & PACS Market Size by Type (2027-2032)
- 8.2.3 Europe Vendor Neutral Archive (VNA) & PACS Market Share by Type (2021-2032)
- 8.3 Europe Vendor Neutral Archive (VNA) & PACS Market Size by Application
- 8.3.1 Europe Vendor Neutral Archive (VNA) & PACS Market Size by Application (2021-2026)
- 8.3.2 Europe Vendor Neutral Archive (VNA) & PACS Market Size by Application (2027-2032)
- 8.3.3 Europe Vendor Neutral Archive (VNA) & PACS Market Share by Application (2021-2032)
- 8.4 Europe Vendor Neutral Archive (VNA) & PACS Market Size by Country
- 8.4.1 Europe Vendor Neutral Archive (VNA) & PACS Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Vendor Neutral Archive (VNA) & PACS Market Size by Country (2021-2026)
- 8.4.3 Europe Vendor Neutral Archive (VNA) & PACS Market Size by Country (2027-2032)
- 8.4.4 Europe Vendor Neutral Archive (VNA) & PACS Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Vendor Neutral Archive (VNA) & PACS Market Size (2021-2032)
- 9.2 China Vendor Neutral Archive (VNA) & PACS Market Size by Type
- 9.2.1 China Vendor Neutral Archive (VNA) & PACS Market Size by Type (2021-2026)
- 9.2.2 China Vendor Neutral Archive (VNA) & PACS Market Size by Type (2027-2032)
- 9.2.3 China Vendor Neutral Archive (VNA) & PACS Market Share by Type (2021-2032)
- 9.3 China Vendor Neutral Archive (VNA) & PACS Market Size by Application
- 9.3.1 China Vendor Neutral Archive (VNA) & PACS Market Size by Application (2021-2026)
- 9.3.2 China Vendor Neutral Archive (VNA) & PACS Market Size by Application (2027-2032)
- 9.3.3 China Vendor Neutral Archive (VNA) & PACS Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Vendor Neutral Archive (VNA) & PACS Market Size (2021-2032)
- 10.2 Asia Vendor Neutral Archive (VNA) & PACS Market Size by Type
- 10.2.1 Asia Vendor Neutral Archive (VNA) & PACS Market Size by Type (2021-2026)
- 10.2.2 Asia Vendor Neutral Archive (VNA) & PACS Market Size by Type (2027-2032)
- 10.2.3 Asia Vendor Neutral Archive (VNA) & PACS Market Share by Type (2021-2032)
- 10.3 Asia Vendor Neutral Archive (VNA) & PACS Market Size by Application
- 10.3.1 Asia Vendor Neutral Archive (VNA) & PACS Market Size by Application (2021-2026)
- 10.3.2 Asia Vendor Neutral Archive (VNA) & PACS Market Size by Application (2027-2032)
- 10.3.3 Asia Vendor Neutral Archive (VNA) & PACS Market Share by Application (2021-2032)
- 10.4 Asia Vendor Neutral Archive (VNA) & PACS Market Size by Country
- 10.4.1 Asia Vendor Neutral Archive (VNA) & PACS Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Vendor Neutral Archive (VNA) & PACS Market Size by Country (2021-2026)
- 10.4.3 Asia Vendor Neutral Archive (VNA) & PACS Market Size by Country (2027-2032)
- 10.4.4 Asia Vendor Neutral Archive (VNA) & PACS Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Vendor Neutral Archive (VNA) & PACS Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Vendor Neutral Archive (VNA) & PACS Market Size by Type
- 11.2.1 South America, Middle East & Africa Vendor Neutral Archive (VNA) & PACS Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Vendor Neutral Archive (VNA) & PACS Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Vendor Neutral Archive (VNA) & PACS Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Vendor Neutral Archive (VNA) & PACS Market Size by Application
- 11.3.1 South America, Middle East & Africa Vendor Neutral Archive (VNA) & PACS Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Vendor Neutral Archive (VNA) & PACS Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Vendor Neutral Archive (VNA) & PACS Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Vendor Neutral Archive (VNA) & PACS Market Size by Country
- 11.4.1 South America, Middle East & Africa Vendor Neutral Archive (VNA) & PACS Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Vendor Neutral Archive (VNA) & PACS Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Vendor Neutral Archive (VNA) & PACS Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Vendor Neutral Archive (VNA) & PACS Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst